Applied Genetic Technologies (AGTC) Tops Q1 EPS by 1c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q1 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $10.3 million, versus $8.44 million reported last year.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance